Murdoch B, Pereira D S, Wu X, Dick J E, Ellis J
Department of Genetics, Hospital for Sick Children, Toronto, Ontario, Canada.
Gene Ther. 1997 Jul;4(7):744-9. doi: 10.1038/sj.gt.3300448.
We have developed a viral RNA (vRNA) dot blot assay for rapid identification of high-titer retrovirus vector production by packaging cell clones. The procedure employs Trizol LS reagent to purify vRNA from packaging cell supernatants, a sensitive dot blot assay, and Phosphorlmager technology to quantify packaged viral genomes in 2 days. Experiments performed on viral supernatants of known biological titer demonstrated that the vRNA dot blot assay was extremely sensitive and that dot intensity correlated directly with viral titer. It is often necessary to analyze approximately 100 virus producing cell clones, making this method useful as a rapid screen to identify the highest virus producing clones. The vRNA dot blot assay consistently identified a subset of candidate high-titer producer cell clones. In three independent screens the supernatant with the highest biological titer was produced by one of the previously defined candidate high-titer producer clones. Our procedure greatly facilitates virus titration by: (1) rapidly eliminating the vast majority of low-titer producer cell clones; (2) accurately identifying the subset of candidate high-titer producer clones for further biological titration and assessment of the proviral genomic structure; and (3) reducing laborious tissue culture manipulations to a minimum. Furthermore, the reliance of this method on molecular detection makes it ideally suited for the isolation of high-titer clones lacking a drug selection marker.
我们开发了一种病毒RNA(vRNA)斑点印迹分析法,用于通过包装细胞克隆快速鉴定高滴度逆转录病毒载体的产生。该方法采用Trizol LS试剂从包装细胞上清液中纯化vRNA,运用灵敏的斑点印迹分析法和磷成像技术,在两天内对包装的病毒基因组进行定量。对已知生物学滴度的病毒上清液进行的实验表明,vRNA斑点印迹分析法极其灵敏,斑点强度与病毒滴度直接相关。通常需要分析大约100个产生病毒的细胞克隆,因此该方法作为一种快速筛选方法,可用于鉴定产生病毒能力最强的克隆。vRNA斑点印迹分析法始终能鉴定出一部分候选高滴度产生细胞克隆。在三次独立筛选中,生物学滴度最高的上清液是由先前确定的候选高滴度产生克隆之一产生的。我们的方法通过以下方式极大地促进了病毒滴度测定:(1)迅速排除绝大多数低滴度产生细胞克隆;(2)准确鉴定候选高滴度产生克隆的子集,以便进一步进行生物学滴度测定和前病毒基因组结构评估;(3)将繁琐的组织培养操作减至最少。此外,该方法依赖分子检测,非常适合分离缺乏药物选择标记的高滴度克隆。